180 Life Sciences CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Forum Markets, Incorporated has announced its 2026 Annual Meeting of Stockholders, scheduled for August 19, 2026, to elect directors, approve executive compensation, and ratify auditor appointments.
ETHZilla Corporation calls a Special Meeting to vote on removing a 20% exchange cap on senior secured convertible notes, potentially leading to significant dilution.
Ethzilla Corporation calls a special meeting to approve the issuance of common stock related to senior secured convertible notes, potentially exceeding 20% of outstanding shares.
ETHZilla Corporation announced significant changes to its board composition and executive compensation, including a director's resignation and new employment terms for its CEO.
ETHZilla Corporation calls a Special Meeting on October 7, 2025, to vote on electing a new director, approving multiple incentive plans, removing a Nasdaq exchange cap on convertible notes, and increasing authorized common stock.
180 Life Sciences Corp. is calling its stockholders to an annual meeting to vote on critical proposals including a reverse stock split, a tenfold increase in authorized common stock, and new equity incentive plans, primarily aimed at maintaining its Nasdaq listing and attracting talent.
180 Life Sciences Corp. announces its Annual Meeting of Stockholders to be held on December 27, 2024, to vote on director elections, incentive plan amendments, executive compensation, stock issuance approvals, auditor ratification, and other business.
DEF 14A: 180 Life Sciences Corp. Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
180 Life Sciences Corp. announces its 2024 annual meeting of stockholders to address director elections, incentive plan amendments, executive compensation, and stock issuance approvals.